Publications

4775 Results

Neurophysiologic alterations induced by vincristine (NSC-67574).

Authors
W Tobin;SG Sandler
Journal / Conference
Cancer Chemo- therapy Reports 52(4):519-526
Year
1968

Chemotherapy for acute leukemia in children: Comparison of cyclophosphamide (NSC-26271) and 6-mercaptopurine (NSC-755)

Authors
DJ Fernbach
Journal / Conference
Cancer Chemotherapy Reports 51:381-387
Year
1967
Research Committee(s)
Leukemia

Cyclophosphamide (NSC-26271) in the treatment of acute leukemia in children

Authors
T Holcomb
Journal / Conference
Cancer Chemotherapy Reports 51:389-392
Year
1967
Research Committee(s)
Leukemia

Clinical studies of 6-methymercaptopurine riboside (NSC-40774) in acute leukemia

Authors
JK Luce;EP Frenkel;TJ Vietti;AA Isassi;KW Hernandez;JP Howard
Journal / Conference
Cancer Chemotherapy Reports 51(7):535-546
Year
1967
Research Committee(s)
Leukemia

Cyclophosphamide (NSC-26271) therapy for children with generalized lymphoma and Hodgkin's disease

Authors
MP Sullivan
Journal / Conference
Cancer Chemotherapy Reports 51:393-396
Year
1967
Research Committee(s)
Lymphoma

Pharmacologic characterization of cyclophosphamide (NSC-26271) and cyclophosphamide metabolites.

Authors
N Brock
Journal / Conference
Cancer Chemotherapy Reports 51:315-325
Year
1967

Studies of some newer phosphoramide mustards.

Authors
OM Friedman
Journal / Conference
Cancer Chemotherapy Reports 51:347-357
Year
1967

Recent biologic and chemical studies of cyclophosphamide (NSC-26271).

Authors
OM Friedman
Journal / Conference
Cancer Chemotherapy Reports 51:327-333
Year
1967

Cyclophosphamide (NSC-26271) in the treatment of children with malignant neoplasm.

Authors
ME Haggard
Journal / Conference
Cancer Chemotherapy Reports 51:403-405
Year
1967

Pharmacologic studies of cyclophosphamide (NSC-26271) and its cogener phosphoramide mustard (NSC-69945).

Authors
TC Hall
Journal / Conference
Cancer Chemotherapy Reports 51:335-340
Year
1967